The whole of my field has been flattened into a single lazy question: Did the health care system fail her?” writes Jennifer ...

Shihipar directs narrative projects and policy impact initiatives at the People, Place, and Health Collective at the Brown ...

More Trump drug pricing deals, GSK speeds up development of mRNA flu vaccine, and other biotech news ...

An NIH proposal to cap the number of research grants investigators can receive has drawn a mixed reception, the agency says.

Novartis and Bristol Myers Squibb have paused multiple cell therapy trials, while $480,000 has now become a routine price for ...

The federal spending bill has an important provision for researchers, and Trump announced more MFN deals with pharma firms.

The House voted to pass a stopgap funding bill that, for now, blocks a White House proposal to give political appointees more ...

Here are some of the key questions about the agreements the Trump administration has reached with drugmakers on pricing.

With clinical success on a personalized mRNA vaccine for melanoma, experts are hoping for a more stable future for the ...

There has been a wealth of new treatment available” for migraine prevention, said a co-author of new guidelines released ...

The Food and Drug Administration on Friday approved a new treatment for a rare and slow-growing cancer that causes an ...

Caution and survival in radiopharmaceuticals, mRNA skepticism, and more biotech news from The Readout ...